diamsar chelate has been researched along with sarcosine in 11 studies
| Studies (diamsar chelate) | Trials (diamsar chelate) | Recent Studies (post-2010) (diamsar chelate) | Studies (sarcosine) | Trials (sarcosine) | Recent Studies (post-2010) (sarcosine) |
|---|---|---|---|---|---|
| 11 | 0 | 4 | 1,550 | 69 | 520 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blekkenhorst, G; Byrne, MJ; Hendry, AJ; Jackson, GE | 1 |
| Danks, DM; McArdle, HJ; Mercer, JF; Sargeson, AM | 1 |
| Creaser, I; Danks, DM; Gross, SM; McArdle, HJ; Sargeson, AM | 1 |
| Bingham, MJ; McArdle, HJ; Sargeson, AM | 1 |
| Chariana, Z; Danzeisen, R; David, S; Fosset, C; McArdle, HJ; Page, K | 1 |
| Di Bartolo, N; Sargeson, AM; Smith, SV | 1 |
| Achilefu, S; Anderson, CJ; Lewis, JS; Wadas, TJ; Wei, L; Welch, MJ; Ye, Y | 1 |
| Cai, H; Conti, PS; Huang, CW; Li, Z; Shahinian, T | 1 |
| Orvig, C; Price, EW | 1 |
| Bardajee, GR; Farahani, BV; Hooshyar, Z; Rajabi, FH | 1 |
| Dianatnejad, N; Hooshyar, Z; Kakavand, N; Khanjari, M; Rezanejade Bardajee, G | 1 |
1 review(s) available for diamsar chelate and sarcosine
| Article | Year |
|---|---|
Matching chelators to radiometals for radiopharmaceuticals.
Topics: Chelating Agents; Chlorobenzenes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcosine; Thermodynamics; Tomography, Emission-Computed, Single-Photon | 2014 |
10 other study(ies) available for diamsar chelate and sarcosine
| Article | Year |
|---|---|
Chromium-cage complex as contrast agent in MR imaging--biodistribution studies of the [57Co]cobalt analogue.
Topics: Animals; Cobalt; Cobalt Radioisotopes; Contrast Media; Heterocyclic Compounds; Kidney; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Radionuclide Imaging; Rhabdomyosarcoma; Sarcosine; Tissue Distribution | 1991 |
Effects of cellular copper content on copper uptake and metallothionein and ceruloplasmin mRNA levels in mouse hepatocytes.
Topics: Animals; Cells, Cultured; Ceruloplasmin; Copper; Female; Gene Expression; Heterocyclic Compounds; Liver; Metallothionein; Mice; Polyamines; RNA, Messenger; Sarcosine | 1990 |
Effect of chelators on copper metabolism and copper pools in mouse hepatocytes.
Topics: Animals; Chelating Agents; Copper; Copper Radioisotopes; Female; Heterocyclic Compounds; Kinetics; Liver; Mice; Penicillamine; Polyamines; Sarcosine | 1989 |
Characterization of intracellular copper pools in rat hepatocytes using the chelator diamsar.
Topics: Animals; Biological Transport; Cells, Cultured; Chelating Agents; Chlorides; Copper; Copper Radioisotopes; Electron Transport Complex IV; Heterocyclic Compounds; Kinetics; Liver; Male; Rats; Rats, Inbred Strains; Sarcosine; Superoxide Dismutase; Temperature; Tritium; Zinc Compounds | 1997 |
Placental ceruloplasmin homolog is regulated by iron and copper and is implicated in iron metabolism.
Topics: Animals; Cell Fractionation; Ceruloplasmin; Choriocarcinoma; Copper; Deferoxamine; Female; Heterocyclic Compounds; Humans; Iron; Iron Chelating Agents; Oxidoreductases; Oxygen; Phenylenediamines; Placenta; Pregnancy; Sarcosine; Tumor Cells, Cultured; Uterine Neoplasms | 2002 |
New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr.
Topics: Animals; Aza Compounds; Chelating Agents; Copper Radioisotopes; Heterocyclic Compounds; Humans; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasms, Experimental; Positron-Emission Tomography; Radiopharmaceuticals; Sarcosine | 2006 |
(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.
Topics: Animals; Binding, Competitive; Chelating Agents; Dipeptides; Heterocyclic Compounds; Humans; Integrin alphaVbeta3; Male; Melanoma; Mice; Neovascularization, Pathologic; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Sarcosine; Staining and Labeling; Tissue Distribution | 2009 |
Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide.
Topics: Animals; Cell Line, Tumor; Copper Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alpha2beta1; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prostatic Neoplasms; Sarcosine; Tissue Distribution; Xenograft Model Antitumor Assays | 2011 |
Study on the interaction of Co (III) DiAmsar with serum albumins: spectroscopic and molecular docking methods.
Topics: Animals; Cattle; Cobalt; Electrochemical Techniques; Heterocyclic Compounds; Humans; Kinetics; Molecular Docking Simulation; Sarcosine; Serum Albumin; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Thermodynamics | 2015 |
Investigations on the interactions of DiAmsar with serum albumins: Insights from spectroscopic and molecular docking techniques.
Topics: Diamines; Dipeptides; Heterocyclic Compounds; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Sarcosine; Serum Albumin; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2015 |